カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界のヒト二倍体細胞培養狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析

◆英語タイトル：Global Human Diploid Cellular Rabies Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書（GIR23SM7878）◆商品コード：GIR23SM7878
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2023年9月
◆ページ数：90
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界のヒト二倍体細胞培養狂犬病ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のヒト二倍体細胞培養狂犬病ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- ヒト二倍体細胞培養狂犬病ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

ヒト二倍体細胞培養狂犬病ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・0.5ml、1ml

用途別セグメント
・病院、診療所

主要な市場プレーヤー
・Chengdu Kanghua、Wyeth Laboratories、Beijing Kangtai Biology、Sanofi Pasteur SA、Merieux Institute、Kanghua Biology

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ヒト二倍体細胞培養狂犬病ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なヒト二倍体細胞培養狂犬病ワクチンメーカーの企業概要、2019年～2022年までのヒト二倍体細胞培養狂犬病ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なヒト二倍体細胞培養狂犬病ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ヒト二倍体細胞培養狂犬病ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのヒト二倍体細胞培養狂犬病ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのヒト二倍体細胞培養狂犬病ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびヒト二倍体細胞培養狂犬病ワクチンの産業チェーンを掲載しています。
・第14、15章では、ヒト二倍体細胞培養狂犬病ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– ヒト二倍体細胞培養狂犬病ワクチンの概要
– タイプ別分析（2018年vs2022年vs2029年）：0.5ml、1ml
– 用途別分析（2018年vs2022年vs2029年）：病院、診療所
– 世界のヒト二倍体細胞培養狂犬病ワクチン市場規模・予測
– 世界のヒト二倍体細胞培養狂犬病ワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Chengdu Kanghua、Wyeth Laboratories、Beijing Kangtai Biology、Sanofi Pasteur SA、Merieux Institute、Kanghua Biology
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：0.5ml、1ml
・用途別分析2018年-2029年：病院、診療所
・ヒト二倍体細胞培養狂犬病ワクチンの北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ヒト二倍体細胞培養狂犬病ワクチンのヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ヒト二倍体細胞培養狂犬病ワクチンのアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ヒト二倍体細胞培養狂犬病ワクチンの南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ヒト二倍体細胞培養狂犬病ワクチンの中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Human Diploid Cellular Rabies Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Diploid Cellular Rabies Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 0.5ml
1.3.3 1ml
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Diploid Cellular Rabies Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.5 Global Human Diploid Cellular Rabies Vaccine Market Size & Forecast
1.5.1 Global Human Diploid Cellular Rabies Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Human Diploid Cellular Rabies Vaccine Sales Quantity (2018-2029)
1.5.3 Global Human Diploid Cellular Rabies Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Chengdu Kanghua
2.1.1 Chengdu Kanghua Details
2.1.2 Chengdu Kanghua Major Business
2.1.3 Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Product and Services
2.1.4 Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Chengdu Kanghua Recent Developments/Updates
2.2 Wyeth Laboratories
2.2.1 Wyeth Laboratories Details
2.2.2 Wyeth Laboratories Major Business
2.2.3 Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Product and Services
2.2.4 Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Wyeth Laboratories Recent Developments/Updates
2.3 Beijing Kangtai Biology
2.3.1 Beijing Kangtai Biology Details
2.3.2 Beijing Kangtai Biology Major Business
2.3.3 Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Product and Services
2.3.4 Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Beijing Kangtai Biology Recent Developments/Updates
2.4 Sanofi Pasteur SA
2.4.1 Sanofi Pasteur SA Details
2.4.2 Sanofi Pasteur SA Major Business
2.4.3 Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Product and Services
2.4.4 Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi Pasteur SA Recent Developments/Updates
2.5 Merieux Institute
2.5.1 Merieux Institute Details
2.5.2 Merieux Institute Major Business
2.5.3 Merieux Institute Human Diploid Cellular Rabies Vaccine Product and Services
2.5.4 Merieux Institute Human Diploid Cellular Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Merieux Institute Recent Developments/Updates
2.6 Kanghua Biology
2.6.1 Kanghua Biology Details
2.6.2 Kanghua Biology Major Business
2.6.3 Kanghua Biology Human Diploid Cellular Rabies Vaccine Product and Services
2.6.4 Kanghua Biology Human Diploid Cellular Rabies Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kanghua Biology Recent Developments/Updates
3 Competitive Environment: Human Diploid Cellular Rabies Vaccine by Manufacturer
3.1 Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Human Diploid Cellular Rabies Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Human Diploid Cellular Rabies Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Human Diploid Cellular Rabies Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Human Diploid Cellular Rabies Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Human Diploid Cellular Rabies Vaccine Manufacturer Market Share in 2022
3.5 Human Diploid Cellular Rabies Vaccine Market: Overall Company Footprint Analysis
3.5.1 Human Diploid Cellular Rabies Vaccine Market: Region Footprint
3.5.2 Human Diploid Cellular Rabies Vaccine Market: Company Product Type Footprint
3.5.3 Human Diploid Cellular Rabies Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Human Diploid Cellular Rabies Vaccine Market Size by Region
4.1.1 Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Human Diploid Cellular Rabies Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Human Diploid Cellular Rabies Vaccine Average Price by Region (2018-2029)
4.2 North America Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029)
4.3 Europe Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029)
4.5 South America Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Human Diploid Cellular Rabies Vaccine Consumption Value by Type (2018-2029)
5.3 Global Human Diploid Cellular Rabies Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Human Diploid Cellular Rabies Vaccine Consumption Value by Application (2018-2029)
6.3 Global Human Diploid Cellular Rabies Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Human Diploid Cellular Rabies Vaccine Market Size by Country
7.3.1 North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Human Diploid Cellular Rabies Vaccine Market Size by Country
8.3.1 Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Human Diploid Cellular Rabies Vaccine Market Size by Region
9.3.1 Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Human Diploid Cellular Rabies Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Human Diploid Cellular Rabies Vaccine Market Size by Country
10.3.1 South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Human Diploid Cellular Rabies Vaccine Market Size by Country
11.3.1 Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Human Diploid Cellular Rabies Vaccine Market Drivers
12.2 Human Diploid Cellular Rabies Vaccine Market Restraints
12.3 Human Diploid Cellular Rabies Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Human Diploid Cellular Rabies Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Diploid Cellular Rabies Vaccine
13.3 Human Diploid Cellular Rabies Vaccine Production Process
13.4 Human Diploid Cellular Rabies Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Diploid Cellular Rabies Vaccine Typical Distributors
14.3 Human Diploid Cellular Rabies Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Chengdu Kanghua Basic Information, Manufacturing Base and Competitors
Table 4. Chengdu Kanghua Major Business
Table 5. Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Product and Services
Table 6. Chengdu Kanghua Human Diploid Cellular Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Chengdu Kanghua Recent Developments/Updates
Table 8. Wyeth Laboratories Basic Information, Manufacturing Base and Competitors
Table 9. Wyeth Laboratories Major Business
Table 10. Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Product and Services
Table 11. Wyeth Laboratories Human Diploid Cellular Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Wyeth Laboratories Recent Developments/Updates
Table 13. Beijing Kangtai Biology Basic Information, Manufacturing Base and Competitors
Table 14. Beijing Kangtai Biology Major Business
Table 15. Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Product and Services
Table 16. Beijing Kangtai Biology Human Diploid Cellular Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Beijing Kangtai Biology Recent Developments/Updates
Table 18. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 19. Sanofi Pasteur SA Major Business
Table 20. Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Product and Services
Table 21. Sanofi Pasteur SA Human Diploid Cellular Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Sanofi Pasteur SA Recent Developments/Updates
Table 23. Merieux Institute Basic Information, Manufacturing Base and Competitors
Table 24. Merieux Institute Major Business
Table 25. Merieux Institute Human Diploid Cellular Rabies Vaccine Product and Services
Table 26. Merieux Institute Human Diploid Cellular Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Merieux Institute Recent Developments/Updates
Table 28. Kanghua Biology Basic Information, Manufacturing Base and Competitors
Table 29. Kanghua Biology Major Business
Table 30. Kanghua Biology Human Diploid Cellular Rabies Vaccine Product and Services
Table 31. Kanghua Biology Human Diploid Cellular Rabies Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Kanghua Biology Recent Developments/Updates
Table 33. Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Human Diploid Cellular Rabies Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Human Diploid Cellular Rabies Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Human Diploid Cellular Rabies Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Human Diploid Cellular Rabies Vaccine Production Site of Key Manufacturer
Table 38. Human Diploid Cellular Rabies Vaccine Market: Company Product Type Footprint
Table 39. Human Diploid Cellular Rabies Vaccine Market: Company Product Application Footprint
Table 40. Human Diploid Cellular Rabies Vaccine New Market Entrants and Barriers to Market Entry
Table 41. Human Diploid Cellular Rabies Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Human Diploid Cellular Rabies Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Human Diploid Cellular Rabies Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Human Diploid Cellular Rabies Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Human Diploid Cellular Rabies Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Human Diploid Cellular Rabies Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Human Diploid Cellular Rabies Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Human Diploid Cellular Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Human Diploid Cellular Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Human Diploid Cellular Rabies Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Human Diploid Cellular Rabies Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Human Diploid Cellular Rabies Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Human Diploid Cellular Rabies Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Human Diploid Cellular Rabies Vaccine Raw Material
Table 101. Key Manufacturers of Human Diploid Cellular Rabies Vaccine Raw Materials
Table 102. Human Diploid Cellular Rabies Vaccine Typical Distributors
Table 103. Human Diploid Cellular Rabies Vaccine Typical Customers
List of Figures
Figure 1. Human Diploid Cellular Rabies Vaccine Picture
Figure 2. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Type in 2022
Figure 4. 0.5ml Examples
Figure 5. 1ml Examples
Figure 6. Global Human Diploid Cellular Rabies Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Clinic Examples
Figure 10. Global Human Diploid Cellular Rabies Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Human Diploid Cellular Rabies Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Human Diploid Cellular Rabies Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Human Diploid Cellular Rabies Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Human Diploid Cellular Rabies Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Human Diploid Cellular Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Human Diploid Cellular Rabies Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Human Diploid Cellular Rabies Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Human Diploid Cellular Rabies Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Human Diploid Cellular Rabies Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 52. China Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Human Diploid Cellular Rabies Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Human Diploid Cellular Rabies Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Human Diploid Cellular Rabies Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Human Diploid Cellular Rabies Vaccine Market Drivers
Figure 73. Human Diploid Cellular Rabies Vaccine Market Restraints
Figure 74. Human Diploid Cellular Rabies Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Human Diploid Cellular Rabies Vaccine in 2022
Figure 77. Manufacturing Process Analysis of Human Diploid Cellular Rabies Vaccine
Figure 78. Human Diploid Cellular Rabies Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のヒト二倍体細胞培養狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析(Global Human Diploid Cellular Rabies Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の凍結乾燥ヒト狂犬病ワクチン（Vero細胞）市場2023年：企業・地域・タイプ・用途別分析
  • 世界のグループA及びC髄膜炎菌多糖体ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の4価髄膜炎菌ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • ヒト用狂犬病ワクチン接種の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆